Smithfield Trust Co - AERIE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Smithfield Trust Co ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$23,000
-14.8%
3,0100.0%0.00%0.0%
Q1 2022$27,000
+28.6%
3,0100.0%0.00%
+100.0%
Q4 2021$21,0003,0100.00%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 805,217$14,212,0004.99%
DAFNA Capital Management LLC 156,842$2,768,0002.34%
NORTHPOINTE CAPITAL LLC 1,034,400$18,257,0002.15%
HARVEY CAPITAL MANAGEMENT INC 223,200$3,856,0001.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,211,644$39,036,0001.30%
Boulegeris Investments, Inc. 88,660$1,565,0001.12%
Partner Investment Management, L.P. 43,623$770,0001.08%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 150,000$2,648,0000.92%
PFM Health Sciences, LP 1,851,564$32,680,0000.83%
Benchmark Capital Advisors 55,400$978,0000.69%
View complete list of AERIE PHARMACEUTICALS INC shareholders